Validating a Hand-Eczema Quality-of-Life Tool in 300 Dutch Adults
Doctor’s Notes · Life in Motion · Evidence Review
Editorial disclosure: The featured scene is an AI-created illustration of fictional people and work settings. It is not a patient, diagnosis, before-and-after image or Dr. Arsy #003 treatment result.
Why this study is useful
This paper asks a focused question about work, daily activity or measurement. Keeping the population, denominator, design and timepoint visible prevents a useful result from becoming an exaggerated promise.
Study snapshot
| Study element | Reported detail |
|---|---|
| Population | 300 Dutch adults with hand eczema at baseline; 166 unchanged participants informed reproducibility |
| Design | Prospective three-timepoint psychometric validation study |
| Timepoint | Baseline, 1–3 days and 4–12 weeks |
| Key result | Agreement ICC was 0.91; smallest detectable change was 14.4 points and minimally important change 11.5, leading authors to recommend at least 15 points as a real important improvement |
What the numbers mean
Agreement ICC was 0.91; smallest detectable change was 14.4 points and minimally important change 11.5, leading authors to recommend at least 15 points as a real important improvement.
Important limitation: Change status relied on patient recall, 73 people already reported change at the short retest, responsiveness was moderate, and thresholds are specific to this Dutch validation.
Questionnaires, examinations, photographs, patch tests and administrative records answer different questions. A screening result can guide the next step, but it does not diagnose the cause of one person’s rash. An association can identify a pattern worth investigating, but it does not prove that a single task, material or personal factor caused every event.
Practical questions for a busy life
- What exposure happens before symptoms: water, soap, gloves, friction, heat, dust, resin, adhesive or another material?
- Which body sites are involved, and does the distribution match the suspected task or equipment?
- What should be tracked: visible severity, sleep, daily function, missed work, presenteeism or safe participation?
- Would occupational-health review, clinician examination or clinician-directed patch testing change the plan?
- What requires prompt medical evaluation, including rapidly spreading redness, drainage, fever, severe pain or major loss of function?
Primary and authoritative sources
- Primary medical research record: PubMed PMID 31560803
- NIAMS: atopic dermatitis overview
- American Academy of Dermatology: skin-care guidance
- NIOSH: occupational skin-exposure recommendations
PubMed indexing is not NIH endorsement of a study’s interpretation, this article or any product.
Where a cosmetic moisturizer fits
Dr. Arsy #003 is a cosmetic moisturizer for hydration, moisture-barrier support and dry-skin comfort. This study did not test #003, and outside research does not become a product result. #003 is not an eczema medicine and this article makes no treatment, cure, prevention, pediatric-safety or 24-hour claim.
Bottom line
The responsible conclusion is narrow: preserve the denominator, comparator, timepoint and limitations, then use the evidence to ask better clinical and exposure-control questions rather than promise a universal result.